Systematic error of serum triglyceride measurements during three decades and the effect of fasting on serum triglycerides in population studies

Clinica Chimica Acta

Volumn 397, Issue 1-2, 2008, Pages 55-59

  Sundvall, Jouko ^a   Laatikainen, Tiina ^b   Hakala, Samu ^b   Leiviskä, Jaana ^a   Alfthan, Georg ^a  

^a Department of Health and Functional Capacity ^*  (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Fasting; population studies; Quality assessment; Serum triglycerides; Systematic error

Indexed keywords

TRIACYLGLYCEROL;

ACCURACY; ARTICLE; DIET RESTRICTION; FEMALE; FINLAND; HEALTH STATUS; HUMAN; HUMAN TISSUE; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; QUALITY CONTROL; QUESTIONNAIRE; SYSTEMATIC ERROR; TRIACYLGLYCEROL BLOOD LEVEL;

CARDIOVASCULAR DISEASES; DIAGNOSTIC ERRORS; FASTING; FEMALE; FINLAND; HUMANS; MALE; QUESTIONNAIRES; RISK FACTORS; TRIGLYCERIDES;

EID: 51249118484     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2008.07.015     Document Type: Article

References (26)

1. Vartiainen E., Jousilahti P., Alfthan G., Sundvall J., Pietinen P., and Puska P. Cardiovascular risk factor changes in Finland 1972-1997. Int J Epidemiol 29 (2000) 49-56
2. Kannel W.B., and D'Agostino R.B. Update of old coronary risk factors. Cardiovasc Risk Factors 6 (1996) 244-253
3. Gaziano J.M. Triglycerides and coronary risk. Curr Cardiol Rep 1 (1999) 125-130
4. Austin M.A. Plasma triglyceride and coronary heart disease. Arterioscler Thromb (1991) 11:2-14
5. Abdel-Maksoud M.F., and Hokanson J.E. The complex role of triglycerides in cardiovascular disease. Semin Vasc Med 2 (2002) 325-333
6. Sarwar N., Danesh J., Eiriksdottir G., et al. Triglycerides and the risk of coronary heart disease: 10 158 incident cases among 262 525 participants in 29 Western prospective studies. Circulation 115 (2007) 450-458
7. Mattsson N., Rönnemaa T., Juonala M., Viikari J.S., and Raitakari O.T. The prevalence of the metabolic syndrome in young adults. The Cardiovascular Risk in Young Finns Study. J Intern Med 261 (2007) 159-169
8. Sundvall J., Leiviskä J., Alfthan G., and Vartiainen E. Serum cholesterol during 27 years: assessment of systematic error and affecting factors and their role in interpreting population trends. Clin Chim Acta 378 (2007) 93-98
9. Klotzsch S.G., and McNamara J.R. Triglyceride measurements: a review of methods and Interferences. Clin Chem 36 (1990) 1605-1613
10. McNamara J.R., Warnick G.R., and Cooper G.R. A brief history of lipid and lipoprotein measurements and their contribution to clinical chemistry. Clin Chim Acta 369 (2006) 158-167
11. Evans K., and Laker M.F. Intra-individual factors affecting lipid, lipoprotein and apolipoprotein measurement: a review. Ann Clin Biochem 32 (1995) 261-280
12. Cooper G.R., Smith S.J., Myers G.L., Sampson E.J., and Magid E. Biological variability in the concentration of serum lipids: sources, meta-analysis, estimation, and minimization by relative range measurements. J Int Fed Clin Chem 7 (1995) 23-28
13. Hugh P., and Barrett R. Kinetics of triglyceride rich lipoproteins: chylomicrons and very low density lipoproteins. Atherosclerosis 141 Suppl 1 (1998) S35-S40
14. Stein E.A., and Myers G.L. National Cholesterol Education Program recommendations for triglyceride measurement: executive summary. The National Cholesterol Education Program Working Group on Lipoprotein Measurement. Clin Chem 41 (1995) 1421-1426
15. Kessler G., and Lederer H. Fluorometric measurements of triglyserides. In: Skeggs Jr. L.T., et al. (Ed). Automation in analytical chemistry. Technicon Symposia 1965 (1966), NY Medical Inc, New York 341-344
16. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigators. J Clin Epidemiol 41 (1988) 105-114
17. Tolonen H., Kuulasmaa K., Laatikainen T., and Wolf H. Recommendation for indicators, international collaboration, protocol and manual of operations for chronic disease risk factor surveys (2002). http://www.ktl.fi/publications/ehrm/product2/title.htm 2002 [cited; Available from: http://www.ktl.fi/publications/ehrm/product2/title.htm]
18. Bland J.M., and Altman D.G. Measuring agreement in method comparison studies. Stat Methods Med Res 8 (1999) 135-160
19. Rustad P., Felding F., Franzson L., et al. The Nordic Reference Interval Project 2000: recommended reference intervals for 25 common biochemical properties. Scan J Clin Lab Invest 64 (2004) 271-284
20. Tolonen H., Wolf H., and Jakovljevic D. The European Health Risk Monitoring Project. Review of surveys for risk factors of major chronic diseases and comparability of the results (2002). http://www.ktl.fi/ehrm October 2002. www-publications from the EHRM Project. URL: http://www.ktl.fi/ehrm
21. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
22. Zech L.A., Grundy S.M., Steinberg D., and Berman M. Kinetic model for production and metabolism of very low density lipoprotein triglycerides. Evidence for a slow production pathway and results for normolipidemic subjects. J Clin Invest 63 (1979) 1262-1273
23. Cohn J.S., McNamara J.R., Cohn S.D., Ordovas J.M., and Schaefer E.J. Postprandial plasma lipoprotein changes in human subjects of different ages. J Lipid Res 29 (1988) 469-479
24. Nordestgaard B.G., Benn M., Schnohr P., and Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 298 (2007) 299-308
25. Bansal S., Buring J.E., Rifai N., Mora S., Sacks F.M., and Ridker P.M. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 298 (2007) 309-316
26. Tirosh A., Rudich A., Shochat T., et al. Changes in triglyseride levels and risk for coronary heart disease in young men. Ann Intern Med 147 (2007) 377-385